Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer

por Wang, Zhenghang, Zhang, Qi, Qi, Changsong, Bai, Yuezong, Zhao, Feilong, Chen, Hui, Li, Zhongwu, Wang, Xicheng, Chen, Mifen, Gong, Jifang, Peng, Zhi, Zhang, Xiaotian, Cai, Jinping, Chen, Shiqing, Zhao, Xiaochen, Shen, Lin, Li, Jian
Publicado 2022

The Optimal Therapy after Progression on Immune Checkpoint Inhibitors in MSI Metastatic Gastrointestinal Cancer Patients: A Multicenter Retrospective Cohort Study

por Chen, Mifen, Wang, Zhenghang, Liu, Zimin, Liu, Ning, Fang, Weijia, Zhang, Hangyu, Jin, Xuan, Li, Jiayi, Zhao, Weifeng, Qu, Huajun, Song, Fanghua, Chang, Zhiwei, Li, Yi, Tang, Yong, Xu, Chunlei, Zhang, Xiaotian, Wang, Xicheng, Peng, Zhi, Cai, Jinping, Li, Jian, Shen, Lin
Publicado 2022

PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study

por Chen, Mifen, Wang, Zhenghang, Liu, Zimin, Deng, Ting, Wang, Xiaodong, Chang, Zhiwei, Zhang, Qi, Yang, Wenlei, Liu, Ning, Ji, Zhi, Zhang, Xiaotian, Wang, Xicheng, Peng, Zhi, Li, Yi, Cao, Yujuan, Jin, Xuan, Lu, Hongxia, Qu, Huajun, Tang, Yong, Xu, Chunlei, Fang, Weijia, Zhang, Hangyu, Yan, Dong, Wang, Li, Li, Jiayi, Zhang, Jingdong, Wang, Qiwei, Xue, Liying, Yin, Fei, Han, Guangjie, Cheng, Zhiqiang, Liu, Qing, Jin, Yongdong, Zhang, Yinjie, Li, Lanxing, Cao, Baoshan, Yao, Yanhong, Chen, Zhiyu, Zou, Jianling, Ying, Jieer, Wei, Qing, Tian, Tiantian, Zhao, Weifeng, Li, Longmei, Zhang, Tong, Song, Fanghua, Ba, Ya-er, Li, Na, Gao, Hui, Ji, Yinghua, Bao, Liying, Zhao, Xiaochen, Cai, Jinping, Yuan, Zheping, Shen, Lin, Li, Jian
Publicado 2023